Oral Presentation Submission 

If your submission is selected, the BMLA will invite you to contribute to the conference as an Oral Presenter. All selected presenters will be required to register for the conference as delegates. 

The BMLA programme must be finalised by 27th Feb to meet the CPD application deadline.

Shine Like Laser Light and Win Prestigious BMLA Awards 

The BMLA will award two prizes for the best oral presenters at the 2026 Annual Conference; prize winners are decided by a judging committee who make their selection based on the quality of the abstracts submitted and the conference oral presentations. The winners are announced on the BMLA website and social media. The BMLA Prizes awarded include: 

•  £100 cash award each
• BMLA Standard Membership for the current year
• One complimentary conference ticket for the next edition of the conference (not including educational courses) 
• One complimentary dinner ticket for the next edition of the conference

The Scientific Chair performs an initial review of all abstract submissions. The Scientific Chair may, at their discretion, re-categorise the abstracts. Abstracts are then submitted to the BMLA conference abstract review panel who review, rank, and select abstracts for presentation at the BMLA Annual Conference. The BMLA conference abstract review panel also take into consideration the following criteria when reviewing abstracts:

• Abstracts should be original and not previously published or presented (clinical series updates and reviews are an exception to this stipulation).
• The selection of talks for presentation will usually be limited to those where the work has been completed at the time of submission. 
• Trials in progress: please submit if you feel that the topic would be of interest to delegates and there will be adequate findings to report on by the date of the conference. Trials in progress have been presented at past conferences and the collaborate and supportive environment has led to productive discussions during the meeting. Not all abstracts will be accepted due to limited space in the programme but the reviewers will provide feedback and will encourage resubmission at future conferences if they feel the trial is at too early a stage.
• The number of patients in the study will be taken into consideration. Scientific, well-designed studies are given preference over anecdotal findings or single case.
• Abstracts must be of high quality and be presented with no bias toward specific companies.
• Each author of an abstract submitted to the BMLA must have made a significant contribution to the research and must assume responsibility for the content of the abstract.
• Full disclosure of Conflict of Interest (COI) is expected and required of ALL presenting authors and co-authors. This should be declared in full during the submission process and on the slides at the start of the presentation.  
• Early Career Research Submissions: BMLA encourages Early Career Researchers to submit their work, including projects that are still in progress or under development. Submissions at this stage are welcome, especially where constructive feedback from the community would be valuable. If your abstract fits this category, please indicate this by selecting “Early Career Research” option when submitting.

(Reviewed by the BMLA Scientific Chair, September 2025)

Before you begin, please gather all information necessary to complete all stages of this process including:

Presentation theme:

Presentation type: Oral Presentation

Abstract content: Title, abstract (summary) and all contributing authors complete with first and last name, organisation (affiliation), city and country. Conflicts and respective company is required.

Abstract (summary) inclusions: Background and Objectives, Study Designs/Materials and Methods, Results, and Conclusion. 

Word count: Title limited to 15 words; Abstract text limited to 250 words.

Make sure your abstract is in on time and in the right format by following these simple steps: